What family of peptides does Testagen belong to?

Testagen is one of the Khavinson short peptide bioregulators, a class of tissue-specific peptides studied in Russia for modulating gene expression and supporting healthy aging.

Is Testagen clinically approved?

No. Testagen is an experimental research peptide. Much of its supporting data comes from bioregulator research rather than large controlled clinical trials, and it is not an approved therapeutic.

← All peptides

Longevity & Anti-aging

Immune

Research Chemical

Testagen

Also known as: Testagen

Testagen is a short synthetic bioregulator peptide from the Khavinson family, studied for effects on the thymus and immune regulation. It is researched for supporting immune balance and healthy aging.

Mechanism of Action

Testagen is a Khavinson-type short peptide bioregulator proposed to act as an epigenetic signal that interacts with regulatory regions of DNA to modulate gene expression in target tissues. It is studied for influencing thymic and lymphoid cell differentiation, helping normalize immune and endocrine function that declines with age. Like other peptide bioregulators, it is thought to support tissue-specific homeostasis rather than acting as a hormone or receptor agonist.

Half-life: Short; small peptides are typically cleared within hours
Administration Routes: subcutaneous
Research Status: Research Chemical